Home | Login | Join | Sitemap | °ü¸®ÀÚ¿¡°Ô
  • ÇÐȸ ¼Ò°³
  • Á¶Á÷µµ
  • ÀÓ¿øÁø
  • ¿ª´ëÀÓ¿øÁø
  • ÆòÀÇ¿ø
  • ÇÐȸ ȸĢ
  • Çмú´ëȸ ¾È³»
  • °ü·Ã Çà»ç ¾È³»
  • Çмú´ëȸ ¿¬Çõ
  • Çмú´ëȸ ÀÚ·á
  • Åõ°í±ÔÁ¤
  • ³í¹®Åõ°í
  • ÇÐȸÁö °Ë»ö
  • ÇÐȸ ¼Ò½ÄÁö
  • ÀϹÝÀÎÀ» À§ÇÑ Áúȯ Á¤º¸
  • ±âŸÀÚ·á½Ç
  • º´¿ø ã±â
  • ÇÐȸ ¼Ò½Ä
  • ȸ¿ø °Ô½ÃÆÇ
  • ȸ¿ø ÀÚ·á½Ç
  • À§¿øȸ °ø°£
  • ȸ¿ø °Ë»ö
  • ÇÐȸ ¾Ù¹ü
Åõ°í±ÔÁ¤
³í¹®Åõ°í
ÇÐȸÁö °Ë»ö
- ÇÐȸÁö »ó¼¼°Ë»ö
- ÇÐȸÁö ±ÇÈ£º°°Ë»ö
ÇÐȸ ¼Ò½ÄÁö
HOME > °£Ç๰ > ÇÐȸÁö °Ë»ö
Korean Journal of Neuromuscular Disorders ; 8 : 1 - 9, June 2016
Clinical Approach to Inherited Muscular Disorders
Down
Hyung Jun Park, MD
Department of Neurology, Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea

Inherited muscular disorders (IMDs) are clinically and genetically heterogeneous groups of genetic
disorders characterized by skeletal muscle weakness. These genetic and phenotypic complexities
of IMDs make it difficult to identify the causative genes by a classical diagnostic approach, using
clinical, pathological and genetic analysis in sequential steps. The recent advance in next generation
sequencing makes it possible to sequence many genes cost-effectively and rapidly and has
improved the molecular diagnosis of IMDs. However, comprehensive analysis of clinical phenotype
is still important and required to identify pathogenic variants among large genomic data including
non-pathogenic variants and sequencing errors. In this article, we provide a comprehensive review
that integrates clinical manifestations and diagnostic strategy.

°Ô½Ã¹°¸ñ·ÏÀ» º¾´Ï´Ù.
(03163) ¼­¿ï Á¾·Î±¸ Àλ絿±æ 12, 1111È£ (Àλ絿, ´ëÀϺôµù)
TEL : 02-720-1594 E-mail : knmd1594@daum.net
Copyright©The Korean Society of Neuromuscular Disorders
TODAY 32 TOTAL 545796